Brought to you by 
Private placement brings 4D pharma £21.5mm
03 Jul 2014
Executive Summary
Four months after completing a £16.6mm IPO, 4D pharma PLC (gut bacteria therapeutics for inflammatory, autoimmune, and GI diseases) raised £21.5mm ($36.6mm) by privately selling 14.3mm shares for £1.50, a 15% discount.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Private placement brings 4D pharma £21.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice